Search references for JJC8 089. Phrases containing JJC8 089
See searches and references containing JJC8 089!JJC8 089
Dopamine reuptake inhibitor related to modafinil
JJC8-089 is a dopamine reuptake inhibitor (DRI) that was derived from modafinil and is related to JJC8-016, JJC8-088, and JJC8-091. Its affinity (Ki) for
JJC8-089
Active component of a pharmaceutical drug
Unlike analogues including JJC8-088, JJC8-089, and RDS03-94, JJC8-091 did not show pro-motivational effects in animals. JJC8-091 was first described in
JJC8-091
GC04-38 – DRI JJC8-016 – poorly selective atypical DRI JJC8-087 – DRI JJC8-088 – classical/typical or cocaine-like DRI JJC8-089 – DRI JJC8-091 – atypical
List of modafinil analogues and derivatives
List_of_modafinil_analogues_and_derivatives
Drug increasing motivation in humans
reuptake inhibitors (DRIs) like bupropion, CE-123, CE-158, CT-005404, JJC8-088, JJC8-089, methylphenidate, (S)-MK-26, modafinil, MRZ-9547 ((R)-phenylpiracetam)
Motivation-enhancing_drug
Synthetic nootropic drug
Pozanicline (INN, codenamed ABT-089) is a drug developed by Abbott, that has nootropic and neuroprotective effects. Animal studies suggested it useful
Pozanicline
JJC8 089
JJC8 089
JJC8 089
JJC8 089
JJC8 089
JJC8 089
JJC8 089
JJC8 089
JJC8 089